← All claims

Sweeteners · Metabolic & Cardiometabolic

xylitol increases cardiovascular disease

In plain terms: Does xylitol raise your risk of heart attack and stroke?

Strong support Sweeteners 🔬 Includes disconfirming

Part of: • xylitol

RefutedContestedStrong support
consensus score 0.80
⚖️ Thin evidence — read the needle loosely. The score shows which way the studies lean, but there are too few independent, high-quality ones to place it firmly. Expect this to move as better evidence arrives.

An early signal resting on very little evidence — a handful of observational studies from a small number of research groups, closely related to the erythritol work. Nobody has run a trial. Worth watching, far too thin to act on.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Population patterns (Observational)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

1 support 1 contradict 0 tested null 2 mixed · 4 sources, 2 independent groups

What the evidence shows

The same group's follow-up (European Heart Journal 2024) reported that elevated plasma xylitol is associated with 3-year cardiovascular events and is prothrombotic in mechanistic assays — mirroring their erythritol findings.

The evidence (4)

SourceGradeStanceQualityFinding
Huang et al.
2025 · Cardiol Rev
observational mixed moderate Review of artificial sweeteners and CVD: xylitol among emerging but non-conclusive concerns.
Wolnerhanssen & Meyer-Gerspach
2025 · Cardiovasc Res
observational mixed moderate Review ('friend or foe?'): xylitol cardiovascular signal from one group; confounded by endogenous production, not replicated like erythritol.
Witkowski et al.
2024 · Eur Heart J
observational supports high Eur Heart J: elevated plasma xylitol associated with 3-yr MACE; xylitol prothrombotic (enhanced platelet aggregation, thrombosis in vivo); ingestion markedly raised plasma xylitol. Notes sugar alcohols are also endogenously produced ~1000× lower than dietary intake.
Huang Z et al
2025 · study_type: in-vitro
in-vitro contradicts low THP-1 monocyte/macrophage model: xylitol reduced LDL-induced oxidative stress (lower ROS, MDA, NADPH-oxidase expression) via Nrf2/HO-1 activation, an antiatherogenic mechanism.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.